Liraglutide Synthetic Peptide C073PS Syd Labs | Ushelf
Liraglutide Synthetic Peptide C073PS Syd Labs | Ushelf

Liraglutide Synthetic Peptide | C073PS

Semaglutide Synthetic Peptide C074PS Syd Labs | Ushelf Semaglutide Synthetic Peptide | C074PS
Liraglutide Synthetic Peptide C073PS Syd Labs | Ushelf

Liraglutide Synthetic Peptide | C073PS

$600.00 – $2,400.00

In stock
Catalog No.: C073PS | In Vivo Grade

$600.00 – $2,400.00

Liraglutide Synthetic Peptide. Liraglutide Synthetic Peptide stable cell line is available for licensing to manufacture the semaglutide biosimilar. The research grade semaglutide biosimilar is for research use only (RUO).

Clear
View cart
Catalog No. C073PS
Product Name Liraglutide Synthetic Peptide
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Source/Host The recombinant peptide liraglutide synthetic peptide was produced in the liraglutide stable cell line.
Applications ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by liraglutide.
Endotoxin < 1 EU per 1 mg of the peptide by the LAL method.
Purity >95% by SDS-PAGE under reducing conditions and HPLC.
Shipping The research grade liraglutide synthetic peptide is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note The research grade liraglutide synthetic peptide is for research use only (RUO).
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C073PS: Liraglutide Synthetic Peptide

Background

What is research grade liraglutide synthetic peptide? Research grade liraglutide synthetic peptide has the same amino acid sequence as Liraglutide, a recombinant peptide which presents 97% homology with human glucagon-like peptide-1 (GLP-1), differing primarily by substituting arginine for lysine at position 34. Liraglutide is made by attaching a C-16 fatty acid (palmitic acid) with a glutamic acid spacer on the remaining lysine residue at position 26 of the peptide precursor. Liraglutide is resistant to the dipeptidylpeptidase-4 enzyme whic degrades the natural hormone. As a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics, Liraglutide actives the GLP-1 receptor and exerts an incretin mimetic effect during at least 24 hours after a single subcutaneous injection. Besides a glucose-dependent stimulatory effect of insulin secretion, liraglutide inhibits glucagon secretion and retards gastric emptying. Liraglutide is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management. Liraglutide is given by injection under the skin. Liraglutide works by increasing insulin release from the pancreas and decreases excessive glucagon release.

Syd Labs also provides the following GLP-1 receptor agonist synthetic peptide:
Semaglutide Synthetic Peptide
Retatrutide Synthetic Peptide
Tirzepatide Synthetic Peptide

Liraglutide Synthetic Peptide from: Liraglutide Synthetic Peptide: C073PS Syd Labs

You may also like…